Regulation of p53 Family Member Isoform ΔNp63α by the Nuclear Factor-κB Targeting Kinase IκB Kinase β

被引:34
作者
Chatterjee, Aditi [1 ]
Chang, Xiaofei [1 ]
Sen, Tanusree [1 ]
Ravi, Rajani [1 ]
Bedi, Atul [1 ]
Sidransky, David [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Head & Neck Canc Res, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21231 USA
关键词
SQUAMOUS-CELL CARCINOMA; CANCER STEM-CELLS; MEDIATED DEGRADATION; INDUCED APOPTOSIS; MUTANT P53; P63; P73; CISPLATIN; PROTEIN; EXPRESSION;
D O I
10.1158/0008-5472.CAN-09-2613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 family gene p63 plays an instrumental role in cellular stress responses including responses to DNA damage. In addition to encoding a full-length transcriptional activator, p63 also encodes several dominant inhibitory isoforms including the isoform Delta Np63 alpha, the function of which is not fully understood. Delta Np63 alpha is degraded in response to DNA damage, thereby enabling an effective cellular response to genotoxic agents. Here, we identify a key molecular mechanism underlying regulation of Delta Np63 alpha expression in response to chemotherapeutic agents or tumor necrosis factor-alpha. We found that Delta Np63 alpha interacts with I kappa B kinase (IKK), a multisubunit protein kinase that consists of two catalytic subunits, IKK alpha and IKK beta, and a regulatory subunit, IKK gamma. The IKK beta kinase promotes ubiquitin-mediated proteasomal degradation of Delta Np63 alpha, whereas a kinase-deficient mutant IKK beta-K44A fails to do so. Cytokine- or chemotherapy-induced stimulation of IKK beta caused degradation of Delta Np63 alpha and augmented transactivation of p53 family-induced genes involved in the cellular response to DNA damage. Conversely, IKK beta inhibition attenuated cytokine- or chemotherapy-induced degradation of Delta Np63 alpha. Our findings show that IKK beta plays an essential role in regulating Delta Np63 alpha in response to extrinsic stimuli. IKK activation represents one mechanism by which levels of Delta Np63 alpha can be reduced, thereby rendering cells susceptible to cell death in the face of cellular stress or DNA damage. Cancer Res; 70(4); 1419-29. (C) 2010 AACR.
引用
收藏
页码:1419 / 1429
页数:11
相关论文
共 41 条
[1]   Mutation of P53 in head and neck squamous cell carcinoma correlates with BCL-2 expression and increased susceptibility to cisplatin-induced apoptosis [J].
Andrews, GA ;
Xi, SC ;
Pomerantz, RG ;
Lin, CJ ;
Gooding, WE ;
Wentzel, AL ;
Sidransky, D ;
Grandis, JR .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (10) :870-877
[2]   U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of ΔNp63α [J].
Chatterjee, Aditi ;
Upadhyay, Sunil ;
Chang, Xiaofei ;
Nagpal, Jatin K. ;
Trink, Barry ;
Sidransky, David .
CELL CYCLE, 2008, 7 (09) :1231-1237
[3]  
Chatterjee S, 2006, FASEB J, V20, pA1261
[4]   The p53 family: same response, different signals? [J].
Chen, XB .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :387-392
[5]   The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways [J].
Dejardin, E ;
Droin, NM ;
Delhase, M ;
Haas, E ;
Cao, YX ;
Makris, C ;
Li, ZW ;
Karin, M ;
Ware, CF ;
Green, DR .
IMMUNITY, 2002, 17 (04) :525-535
[6]  
Demonacos Constantinos, 2003, Prog Cell Cycle Res, V5, P375
[7]   Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis [J].
Eyler, Christine E. ;
Rich, Jeremy N. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (17) :2839-2845
[8]   Epidermal stem cells and cancer stem cells: Insights into cancer and potential therapeutic strategies [J].
Finlan, L. E. ;
Hupp, T. R. .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (09) :1283-1292
[9]   Phase III comparison of high-dose paclitaxel plus cisplatin plus granulocyte colony-stimulating factor versus low-dose paclitaxel plus cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393 [J].
Forastiere, AA ;
Leong, T ;
Rowinsky, E ;
Murphy, BA ;
Vlock, DR ;
DeConti, RC ;
Adams, GL .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1088-1095
[10]   AIS is an oncogene amplified in squamous cell carcinoma [J].
Hibi, K ;
Trink, B ;
Patturajan, M ;
Westra, WH ;
Caballero, OL ;
Hill, DE ;
Ratovitski, EA ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5462-5467